Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Scythian Biosciences Corp (SCYB.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 09/30

(Values in thousands)

	12-2022	09-2022	06-2022	03-2022	12-2021
Assets
Current Assets
Cash & Cash Equivalents	281	368	288	254	2,060
Receivables	3,785	3,204	2,368	3,066	3,347
TOTAL	$4,382	$3,832	$2,987	$3,429	$5,832

Non-Current Assets
PPE Net	383	447	531	283	320
Investments And Advances	1,410	1,368	2,125	2,374	3,105
Intangibles	4,455	5,497	5,259	5,505	7,042
Other Non-Current Assets	76	76	73	73	73
TOTAL	$6,323	$7,388	$7,988	$8,236	$10,542

Total Assets	$10,704	$11,220	$10,975	$11,665	$16,374

Liabilities
Current Liabilities
Short Term Debt	60	60	60	60	60
Accounts payable and accrued liabilities	N/A	N/A	544	N/A	N/A
TOTAL	$1,861	$1,544	$2,267	$864	$960

Non-Current Liabilities
Long Term Debt	113	3,830	123	67	123
Other Non-Current Liabilities	-408	0	0	0	0
TOTAL	$228	$3,935	$821	$383	$371

Total Liabilities	$2,089	$5,479	$3,088	$1,248	$1,331

Shareholders' Equity
Common Shares	44,373	44,583	44,583	44,583	44,425
Retained earnings	-68,307	-62,280	-58,798	-56,055	-51,974
Other shareholders' equity	7,800	2,836	6,954	6,954	7,655
TOTAL	$8,207	$5,741	$7,887	$10,418	$15,043

Total Liabilities And Equity	$10,296	$11,220	$10,975	$11,665	$16,374